Kristen Acosta’s practice focuses on advising public and private companies on a variety of complex transactions, including domestic and cross-border mergers, asset and stock acquisitions, and private equity investments. She also has experience in advising clients with respect to corporate governance and other general corporate matters. Kristen has advised clients across a broad range of industries, including food manufacturing, healthcare, insurance, software, and technology.
Experience
- Mayne Pharma Group Limited (ASX: MYX) in the sale of its generic prescription product portfolio to Dr. Reddy's Laboratories SA (NYSE: RDY).
- Vela Industries Group in its acquisition of Samtech, a Chile-based fleet management, machine performance, and telematics software and hardware provider for the mining, construction, and rental fleet industries in Chile and Colombia.
- Jose Seripieri Filho in his acquisition of Amil, a leading healthcare operator and insurance provider in Brazil, from UnitedHealth Group Inc. (NYSE: UNH). This acquisition was awarded “Cross Border Deal of the Year ($1B To $10B)” (International M&A Awards).
- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, in the sale of its clinical services business to Audax Private Equity, a leading middle market investment firm, for a total value of approximately $650 million.
Perspectives
Credentials
Education
- B.A., Philosophy, Politics, and Law; Political Science, SUNY at Binghamton, 2016
- J.D., cum laude, Business Honors Concentration, Maurice A. Deane School of Law at Hofstra University, 2019
Admissions
- New York